Abstract
Introduction
The postnatal, neurodevelopmental disorder Rett syndrome (RTT, MIM 312750 ) is caused by mutations in the gene encoding the methyl-CpG binding protein 2 (MeCP2) [1] . MECP2 mutations have been identified in approximately 90% of classical RTT patients. This genetic disease is characterized by a postnatal, normal development for the first few months followed by developmental stagnation and regression, loss of purposeful hand movements and speech, truncal ataxia, stereotypic hand movements, deceleration of brain growth, autonomic dysfunction and seizures [2] . [3] , but also binds to unmethylated four-way DNA junctions with a similar affinity, indicating a role of MeCP2 in higher-order chromatin interaction [2] . The function of MeCP2 as a transcriptional repressor was first suggested based on in vitro experiments. It was shown to specifically inhibit transcription of genes with methylated promoters after binding to methylated CpG dinucleotides via its MBD, and recruiting the corepressor Sin3A and histone deacetylases 1 and 2 by its transcriptional repression domain [4, 5] .
MeCP2 is a member of the methyl-CpG binding protein family, and is composed by three domains: the methyl-binding domain (MBD), the transcriptional repression domain and a C-terminal domain, in addition to two nuclear localization signals. The MBD specifically binds to methylated CpG dinucleotides, with higher affinity for CpG sequences with adjacent A/T-rich motifs

The transcriptional repressor activity of MeCP2 involves the compaction of chromatin by promoting nucleosome clustering, either through the recruitment of histone deacetylase and histone deacetylation or through a direct interaction between its C-terminal domain and chromatin. However, recent studies suggest that MeCP2 regulates the expression of a wide range of genes and that it can both
repress and activate transcription [6, 7] . [8] . However, a recent study using hypothalamus tissues from Mecp2-null mice and Mecp2-transgenic mice showed that more than 2100 genes are misregulated in both mouse models, although the magnitude of the changes in expression levels for both activated and repressed genes was moderate [6] . Several studies have also used the candidate gene approach in samples from both human and mouse tissues, and identified putative MeCP2 targets that might be relevant to the pathogenesis of RTT [9] [10] [11] [12] . Some of these targets, such as the brain-derived neurotrophic factor and the phospholemman precursor (FXYD1) have been confirmed, mainly in mice models, while others, such as DLX5 and UBE3A, were found inconsistently differentially expressed [13] [14] . In 
Given that RTT may likely result from dysfunction of a putative transcriptional modulator activity of MeCP2, several groups have developed strategies to identify the transcriptional targets of MeCP2 in order to gain insights into the disease pathogenesis. Transcriptional profiling studies using brain tissue from Mecp2-null mice did not reveal major changes in gene expression, suggesting that MeCP2 may not be a global transcriptional repressor as previously thought, and that loss of MeCP2 function leads to subtle gene expression variations
Immunocytochemical analysis with MeCP2 antibody
MeCP2 protein expression in fibroblasts was determined by immunofluorescence analysis as previously described [17] . [19] .
Quantitative real-time PCR
Total RNA from the clonal cultures was converted, as described above, to cDNA for quantitative real-time PCR with SYBR Green as (Fig. 3) . Fig. 4A) [26] . Though mechanisms underlying this discordance remain to be further investigated, recent studies have shown that at least 1000 autosomal human genes are subjected to random monoallelic expression [27] . Similarly [30] .
R255X mutation. (A), (B), (G) and (H) show wild-type clonal cultures immunostained with DAPI (B, H) and FITC-conjugated MeCP2 antibody (A, G). (D), (E), (J) and (K) show mutated clonal cultures immunostained with DAPI (E, K) and FITC-conjugated MeCP2 antibody (D, J). (C), (F) and (I) represent merged pictures. All wild-type and mutated cells from the patient show positive staining with the antibody against the N-terminal epitope. Cells from mutated clonal cultures show no signal with the antibody against the C-terminal epitope.
Table 5 Genes with higher expression (Ͼ2 fold change in expression level) and with lower expression (Ͻ0.5 fold change in expression level) in mutant samples on microarray analysis. This table contains the list of genes significantly dysregulated in at least one of the three statistical analysis (paired-t-Test; unpaired-t-Test, and Genespring) (P Ͻ 0.05). ns: not significant
ChIP and bisulphite-converted DNA sequencing of up-regulated target genes
To determine whether MeCP2 directly binds to the potential overexpressed target genes, we carried out ChIP assays using a normal human fibroblast cell culture and either an anti-MeCP2 antibody or a control IgG antibody. The immunoprecipitated chromatin was used as a template for subsequent amplifications of CpG-rich domains found in the close vicinity of our candidate genes except for PCDHB14 where the CpG island is located within exon 1 (
Another interesting target gene is CADM1. The product of the gene is an immunoglobulin-like intercellular, adhesion molecule that plays a critical role in the telencephalon and cerebellum development [31] . Moreover, this gene is localized in an interval in which a small 11q23.3 de novo duplication has been associated with atypical RTT in a girl [32] . 
